levosalbutamol + ambroxol + guaifenesin

Vocuff-LS is a combination pharmaceutical product marketed by Skyways Healthcare, primarily used for the treatment of productive cough associated with bronchospasm. It contains three active ingredients: levosalbutamol, a selective beta-2 adrenergic receptor agonist that promotes bronchodilation; ambroxol, a mucolytic agent that reduces the viscosity of mucus; and guaifenesin, an expectorant that increases the volume of airway secretions to facilitate their expulsion. This combination is commonly utilized in the management of respiratory conditions such as bronchitis and bronchial asthma where both airway constriction and mucus accumulation are present. As a branded generic formulation, it is distributed through the PCD (Propaganda Cum Distribution) franchise model in India.

Brand names

Vocuff-LS

Other names

Levosalbutamol/Ambroxol/Guaifenesin